发明名称 |
CD138-TARGETED CELL AGENTS AND USING THEM |
摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to biotechnology and immunology. What is presented is a genetically engineered antibody able to bind human CD138. There are described its heavy and light chain sequences, as well as their CDR.EFFECT: presented antibody can be used as an ingredient of a pharmaceutical composition for treating tumours.13 cl, 21 dwg, 5 tbl |
申请公布号 |
RU2537265(C2) |
申请公布日期 |
2014.12.27 |
申请号 |
RU20100130994 |
申请日期 |
2008.12.23 |
申请人 |
BIOTEST AG |
发明人 |
KRAUS,EHL'MAR;BRJUKHER,KRISTOF;DELKEN,BENZHAMIN;GERMER,MATTIAS;TSENG,SHTEFFEN;OSTERROT,FRANK;UEHREK,KRISTOF;AJGNER,ZIL'KE;SHUL'TS,GREGOR |
分类号 |
C07K16/30;A61K39/395;A61P35/00 |
主分类号 |
C07K16/30 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|